{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:12:34Z","timestamp":1793776354960,"version":"4.6.1"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003803","name":"The University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.molmed.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:19:14Z","timestamp":1782965954000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting amino acid metabolism in hepatocellular carcinoma"],"prefix":"10.1016","author":[{"given":"Yibing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Chak-Lui","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2026.06.002_bb0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-pathmechdis-031521-024831","article-title":"Spatiotemporal metabolic liver zonation and consequences on pathophysiology","volume":"18","author":"Martini","year":"2023","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.molmed.2026.06.002_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41419-024-06435-w","article-title":"Amino acid metabolism in tumor biology and therapy","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.molmed.2026.06.002_bb0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s12276-025-01415-2","article-title":"Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications","volume":"57","author":"Park","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.molmed.2026.06.002_bb0020","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2015.447","article-title":"Glutaminolysis as a target for cancer therapy","volume":"35","author":"Jin","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2026.06.002_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101694","article-title":"Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism","volume":"70","author":"Ferguson","year":"2023","journal-title":"Mol. Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202202104","article-title":"Genome-wide CRISPR\/Cas9 library screening revealed dietary restriction of glutamine in combination with inhibition of pyruvate metabolism as effective liver cancer treatment","volume":"9","author":"Yang","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.molmed.2026.06.002_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202401399","article-title":"Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A\u2014modification promotes lenvatinib resistance in HCC","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.molmed.2026.06.002_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.aab2674","article-title":"Sestrin2 is a leucine sensor for the mTORC1 pathway","volume":"351","author":"Wolfson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.06.002_bb0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature19079","article-title":"Mechanism of arginine sensing by CASTOR1 upstream of mTORC1","volume":"536","author":"Saxton","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.06.002_bb0050","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1126\/science.aao3265","article-title":"SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway","volume":"358","author":"Gu","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.06.002_bb0055","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jhep.2015.07.039","article-title":"CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt\/mTOR\/SREBP1c and P38\/PPAR\u03b1 pathways","volume":"63","author":"Li","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0060","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jhep.2022.11.017","article-title":"Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma","volume":"78","author":"Sun","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0065","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/s42255-021-00487-4","article-title":"Serine catabolism generates liver NADPH and supports hepatic lipogenesis","volume":"3","author":"Zhang","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0070","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.cmet.2024.10.001","article-title":"Amino acid is a major carbon source for hepatic lipogenesis","volume":"36","author":"Liao","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cmet.2024.10.013","article-title":"A hierarchical hepatic de novo lipogenesis substrate supply network utilizing pyruvate, acetate, and ketones","volume":"37","author":"Rauckhorst","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0080","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.cmet.2018.04.015","article-title":"The BCKDH kinase and phosphatase integrate BCAA and lipid metabolism via regulation of ATP-citrate lyase","volume":"27","author":"White","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0085","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cmet.2020.01.013","article-title":"Targeting hepatic glutaminase 1 ameliorates non-alcoholic steatohepatitis by restoring very-low-density lipoprotein triglyceride assembly","volume":"31","author":"Simon","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0090","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1038\/ncomms4083","article-title":"Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease","volume":"5","author":"Mardinoglu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.06.002_bb0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/abbs\/gmz005","article-title":"Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma","volume":"51","author":"Tao","year":"2019","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.molmed.2026.06.002_bb0100","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aec0766","article-title":"Impaired nitrogenous waste clearance promotes hepatocellular carcinoma","volume":"12","author":"Han","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molmed.2026.06.002_bb0105","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","article-title":"Arginine reprograms metabolism in liver cancer via RBM39","volume":"186","author":"Mossmann","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2026.06.002_bb0110","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cmet.2022.06.010","article-title":"GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment","volume":"34","author":"Missiaen","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0115","article-title":"Loss of carbamoyl phosphate synthetase 1 potentiates hepatocellular carcinoma metastasis by reducing aspartate level","volume":"11","author":"Chen","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.molmed.2026.06.002_bb0120","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161408","article-title":"Glutamine synthetase limits \u03b2-catenin\u2013mutated liver cancer growth by maintaining nitrogen homeostasis and suppressing mTORC1","volume":"132","author":"Dai","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2026.06.002_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111691","article-title":"Branched-chain amino acid catabolism breaks glutamine addiction to sustain hepatocellular carcinoma progression","volume":"41","author":"Yang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2026.06.002_bb0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","article-title":"Nucleotide metabolism: a pan-cancer metabolic dependency","volume":"23","author":"Mullen","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2026.06.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000769","article-title":"ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance","volume":"9","author":"Ming","year":"2025","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.molmed.2026.06.002_bb0140","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1016\/j.molcel.2021.08.005","article-title":"The context-specific roles of urea cycle enzymes in tumorigenesis","volume":"81","author":"Hajaj","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2026.06.002_bb0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature15529","article-title":"Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis","volume":"527","author":"Rabinovich","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.06.002_bb0150","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/ncb3389","article-title":"Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth","volume":"18","author":"Cox","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0155","article-title":"Targeting mTORC2\/HDAC3 inhibits stemness of liver cancer cells against glutamine starvation","volume":"9","author":"Zhang","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.molmed.2026.06.002_bb0160","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cmet.2022.04.006","article-title":"Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth","volume":"34","author":"Mukha","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0165","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1038\/s41467-018-07868-6","article-title":"Serine synthesis through PHGDH coordinates nucleotide levels by maintaining central carbon metabolism","volume":"9","author":"Reid","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.06.002_bb0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative stress in cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2026.06.002_bb0175","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1038\/s41467-019-12606-7","article-title":"Genome-wide CRISPR\/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC","volume":"10","author":"Wei","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.06.002_bb0180","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1016\/j.ymthe.2024.10.025","article-title":"N6-methyladenosine modification activates the serine synthesis pathway to mediate therapeutic resistance in liver cancer","volume":"32","author":"Chan","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2026.06.002_bb0185","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41467-023-36708-5","article-title":"PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.06.002_bb0190","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/antiox12091653","article-title":"Oxidative stress in liver pathophysiology and disease","volume":"12","author":"Allameh","year":"2023","journal-title":"Antioxidants (Basel)."},{"key":"10.1016\/j.molmed.2026.06.002_bb0195","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.molmed.2026.06.002_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123965","article-title":"Reprogramming cysteine metabolism via METTL14-SLC7A11 axis promotes the progression of NAFLD and hepatocellular carcinoma","volume":"380","author":"He","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.molmed.2026.06.002_bb0205","article-title":"Targeting USP8 inhibits O-GlcNAcylation of SLC7A11 to promote ferroptosis of hepatocellular carcinoma via stabilization of OGT","volume":"10","author":"Tang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.molmed.2026.06.002_bb0210","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41419-024-07198-0","article-title":"Integration of epigenomic and transcriptomic profiling uncovers EZH2 target genes linked to cysteine metabolism in hepatocellular carcinoma","volume":"15","author":"Lee","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.molmed.2026.06.002_bb0215","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.freeradbiomed.2023.09.006","article-title":"Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-Myc complex-mediated glutamine starvation","volume":"208","author":"Zeng","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.molmed.2026.06.002_bb0220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ebiom.2018.11.063","article-title":"Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt\/beta-catenin pathway","volume":"39","author":"Li","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.molmed.2026.06.002_bb0225","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cmet.2023.12.013","article-title":"Serine synthesis via reversed SHMT2 activity drives glycine depletion and Acetaminophen hepatotoxicity in MASLD","volume":"36","author":"Ghrayeb","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0230","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1038\/s41388-024-03122-0","article-title":"The methionine cycle and its cancer implications","volume":"43","author":"Tassinari","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2026.06.002_bb0235","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3350\/cmh.2025.0048","article-title":"Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Kakazu","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1096\/fasebj.14.1.95","article-title":"Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation: implications for MAT1A silencing during transformation","volume":"14","author":"Torres","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.molmed.2026.06.002_bb0245","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s43018-023-00671-3","article-title":"Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 inhibition in liver cancer","volume":"5","author":"Li","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.molmed.2026.06.002_bb0250","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cmet.2015.08.024","article-title":"Histone methylation dynamics and gene regulation occur through the sensing of one-carbon metabolism","volume":"22","author":"Mentch","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0255","doi-asserted-by":"crossref","first-page":"17480","DOI":"10.1073\/pnas.1312022110","article-title":"Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription","volume":"110","author":"Xu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2026.06.002_bb0260","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-020-01172-y","article-title":"The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.molmed.2026.06.002_bb0265","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.7150\/thno.99633","article-title":"Oncofetal TRIM71 drives liver cancer carcinogenesis through remodeling CEBPA-mediated serine\/glycine metabolism","volume":"14","author":"Su","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.molmed.2026.06.002_bb0270","article-title":"m6A-Modified circRAPGEF1 interaction with IGF2BP3 promotes hepatocellular carcinoma progression via reprogramming aspartate metabolism","volume":"12","author":"Shi","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.molmed.2026.06.002_bb0275","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.cmet.2025.02.008","article-title":"Pyruvate metabolism enzyme DLAT promotes tumorigenesis by suppressing leucine catabolism","volume":"37","author":"Wang","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217006","article-title":"CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer","volume":"595","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.molmed.2026.06.002_bb0285","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/liv.14692","article-title":"The biological process of lysine-tRNA charging is therapeutically targetable in liver cancer","volume":"41","author":"Zhang","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.molmed.2026.06.002_bb0290","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41418-024-01323-4","article-title":"The tRNA Gm18 methyltransferase TARBP1 promotes hepatocellular carcinoma progression via metabolic reprogramming of glutamine","volume":"31","author":"Shi","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2026.06.002_bb0295","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jhep.2025.06.034","article-title":"Mevalonate pathway promotes liver cancer by suppressing ferroptosis through CoQ10 production and selenocysteine-tRNA modification","volume":"83","author":"Chen","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0300","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022111550","article-title":"Non-canonical phosphoglycerate dehydrogenase activity promotes liver cancer growth via mitochondrial translation and respiratory metabolism","volume":"41","author":"Shu","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2026.06.002_bb0305","doi-asserted-by":"crossref","DOI":"10.1126\/science.adv7129","article-title":"The origin of hepatocellular carcinoma depends on metabolic zonation","volume":"391","author":"Guo","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.06.002_bb0310","doi-asserted-by":"crossref","DOI":"10.1126\/science.1242454","article-title":"Fueling immunity: insights into metabolism and lymphocyte function","volume":"342","author":"Pearce","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.06.002_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116463","article-title":"Metabolic regulation of immunity in the tumor microenvironment","volume":"44","author":"Li","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2026.06.002_bb0320","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.0903586","article-title":"Glutamine uptake and metabolism are coordinately regulated by ERK\/MAPK during T lymphocyte activation","volume":"185","author":"Carr","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0325","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cmet.2016.12.011","article-title":"Serine is an essential metabolite for effector T cell expansion","volume":"25","author":"Ma","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0330","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ni.2556","article-title":"Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation","volume":"14","author":"Sinclair","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0335","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.celrep.2019.08.034","article-title":"T cell activation depends on extracellular alanine","volume":"28","author":"Ron-Harel","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2026.06.002_bb0340","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41556-020-00615-4","article-title":"Asparagine enhances LCK signalling to potentiate CD8+ T-cell activation and anti-tumour responses","volume":"23","author":"Wu","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0345","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","article-title":"Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization","volume":"42","author":"Jha","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2026.06.002_bb0350","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s12276-024-01214-1","article-title":"Glutamine-derived aspartate is required for eIF5A hypusination-mediated translation of HIF-1\u03b1 to induce the polarization of tumor-associated macrophages","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.molmed.2026.06.002_bb0355","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.immuni.2021.10.009","article-title":"Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters","volume":"54","author":"Grzes","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2026.06.002_bb0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2014.12.030","article-title":"The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo","volume":"42","author":"Blagih","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2026.06.002_bb0365","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-repopulating cells induce PD-1 expression in CD8+ T cells by transferring kynurenine and AhR activation","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2026.06.002_bb0370","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/s41467-021-21804-1","article-title":"Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma","volume":"12","author":"Hung","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.06.002_bb0375","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1111\/cas.16336","article-title":"Loss of USP10 promotes hepatocellular carcinoma proliferation by regulating the serine synthesis pathway through inhibition of LKB1 activity","volume":"115","author":"Ma","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.molmed.2026.06.002_bb0380","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adg8817","article-title":"Serine enrichment in tumors promotes regulatory T cell accumulation through sphinganine-mediated regulation of c-Fos","volume":"9","author":"Ma","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0385","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1158\/0008-5472.CAN-24-3180","article-title":"SLC3A2-mediated lysine uptake by cancer cells restricts T-cell activity in hepatocellular carcinoma","volume":"85","author":"Chang","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2026.06.002_bb0390","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gutjnl-2024-332429","article-title":"Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A+ myeloid cells to promote liver cancer progression","volume":"74","author":"Yang","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2026.06.002_bb0395","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","article-title":"SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity","volume":"620","author":"Guo","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.06.002_bb0400","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140100","article-title":"Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer","volume":"131","author":"Edwards","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2026.06.002_bb0405","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-22-3042","article-title":"Metformin reprograms tryptophan metabolism to stimulate CD8+ T-cell function in colorectal cancer","volume":"83","author":"Huang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2026.06.002_bb0410","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","article-title":"Neutrophil profiling illuminates anti-tumor antigen-presenting potency","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2026.06.002_bb0415","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","article-title":"Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures","volume":"43","author":"Tang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2026.06.002_bb0420","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2026.06.002_bb0425","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1158\/0008-5472.CAN-22-3561","article-title":"PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression","volume":"83","author":"Zhou","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2026.06.002_bb0430","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/0008-5472.CAN-22-0042","article-title":"GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2026.06.002_bb0435","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1172\/JCI75836","article-title":"Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis","volume":"125","author":"Xiang","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2026.06.002_bb0440","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2023.10.024","article-title":"Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism","volume":"80","author":"Zhang","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2019.04.005","article-title":"GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT\/GSK3\u03b2\/CyclinD1 pathway","volume":"381","author":"Xi","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.molmed.2026.06.002_bb0450","article-title":"The glutaminase-1 inhibitor 968 enhances dihydroartemisinin-mediated antitumor efficacy in hepatocellular carcinoma cells","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2026.06.002_bb0455","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.3390\/cells11233924","article-title":"Unbalanced glutamine partitioning between CD8T cells and cancer cells accompanied by immune cell dysfunction in hepatocellular carcinoma","volume":"11","author":"Chen","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.molmed.2026.06.002_bb0460","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jconrel.2023.11.054","article-title":"Hypoxia-activated glutamine antagonist prodrug combined with combretastatin A4 nanoparticles for tumor-selective metabolic blockade","volume":"365","author":"Zheng","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.molmed.2026.06.002_bb0465","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56749","article-title":"A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer","volume":"9","author":"Jin","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.molmed.2026.06.002_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1185985","article-title":"Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma","volume":"14","author":"Liang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0475","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76958-7","article-title":"Metabolic interaction between amino acid deprivation and cisplatin synergistically reduces phosphoribosyl-pyrophosphate and augments cisplatin cytotoxicity","volume":"10","author":"Wahwah","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2026.06.002_bb0480","first-page":"5443","article-title":"Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo","volume":"62","author":"Ensor","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2026.06.002_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107890","article-title":"Oncogenic accumulation of cysteine promotes cancer cell proliferation by regulating the translation of D-type cyclins","volume":"300","author":"Okano","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2026.06.002_bb0490","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41419-021-03456-7","article-title":"BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.molmed.2026.06.002_bb0495","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1093\/annonc\/mdy101","article-title":"Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma","volume":"29","author":"Abou-Alfa","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0500","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1943253","article-title":"Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers","volume":"10","author":"Chang","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.molmed.2026.06.002_bb0505","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00280-018-3635-3","article-title":"A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies","volume":"82","author":"Harding","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0510","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nut.2016.07.013","article-title":"Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: a randomized trial","volume":"33","author":"Nojiri","year":"2017","journal-title":"Nutrition"},{"key":"10.1016\/j.molmed.2026.06.002_bb0515","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4143\/crt.2011.43.1.24","article-title":"Effect of oral supplementation with branched-chain amino acid (BCAA) during radiotherapy in patients with hepatocellular carcinoma: a double-blind randomized study","volume":"43","author":"Lee","year":"2011","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.molmed.2026.06.002_bb0520","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1158\/1078-0432.CCR-21-1204","article-title":"A phase I dose-escalation and expansion study of telaglenastat in patients with advanced or metastatic solid tumors","volume":"27","author":"Harding","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2026.06.002_bb0525","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.cmet.2024.10.019","article-title":"Dual impacts of serine\/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation","volume":"36","author":"Tong","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0530","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10637-023-01416-w","article-title":"Phase I\/II trial of BMS-986,205 and nivolumab as first line therapy in hepatocellular carcinoma","volume":"42","author":"Huynh","year":"2024","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.molmed.2026.06.002_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103813","article-title":"Asparagine synthetase modulates glutaminase inhibitor sensitivity through metabolic reprogramming and serves as a prognostic biomarker in hepatocellular carcinoma","volume":"86","author":"Gao","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0540","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.06.002_bb0545","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12951-022-01424-7","article-title":"Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancer","volume":"20","author":"Tang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0550","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fonc.2018.00423","article-title":"Updates in the clinical development of epacadostat and other indoleamine 2,3-dioxygenase 1 inhibitors (IDO1) for human cancers","volume":"8","author":"Komiya","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0555","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1038\/s41467-024-47868-3","article-title":"Tryptophan fuels MYC-dependent liver tumorigenesis through indole 3-pyruvate synthesis","volume":"15","author":"Venkateswaran","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.06.002_bb0560","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s42255-023-00856-1","article-title":"Asparagine restriction enhances CD8+ T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response","volume":"5","author":"Gnanaprakasam","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.molmed.2026.06.002_bb0565","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/gutjnl-2022-326928","article-title":"Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts","volume":"72","author":"Li","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2026.06.002_bb0570","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00281-018-0702-0","article-title":"Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond","volume":"41","author":"Muller","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.104536","article-title":"A phase I\/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer","volume":"10","author":"Gouda","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.molmed.2026.06.002_bb0580","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jhep.2023.10.040","article-title":"Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours","volume":"80","author":"Celsa","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2026.06.002_bb0585","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000063","article-title":"Hepatotoxicity of immune checkpoint inhibitors: what is currently known","volume":"7","author":"Zheng","year":"2023","journal-title":"Hepatol. Commun."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426001383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426001383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:27:20Z","timestamp":1783211240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491426001383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":117,"alternative-id":["S1471491426001383"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2026.06.002","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting amino acid metabolism in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}